|
C12ORF66 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.601620E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.195200E-03 |
| Normal-vs-Stage2 |
2.685400E-01 |
| Normal-vs-Stage3 |
3.774400E-01 |
| Normal-vs-Stage4 |
2.774800E-01 |
| Stage1-vs-Stage2 |
7.406000E-01 |
| Stage1-vs-Stage3 |
4.156800E-01 |
| Stage1-vs-Stage4 |
8.247600E-01 |
| Stage2-vs-Stage3 |
7.601600E-01 |
| Stage2-vs-Stage4 |
9.789600E-01 |
| Stage3-vs-Stage4 |
7.702200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.883820E-02 |
| Normal-vs-AfricanAmerican |
8.944900E-03 |
| Normal-vs-Asian |
4.549600E-01 |
| Caucasian-vs-AfricanAmerican |
4.263400E-01 |
| Caucasian-vs-Asian |
8.318400E-01 |
| AfricanAmerican-vs-Asian |
9.479200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.802550E-03 |
| Normal-vs-Female |
9.677600E-01 |
| Male-vs-Female |
2.734300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.891640E-01 |
| Normal-vs-Extreme_Weight |
1.811560E-04 |
| Normal-vs-Obese |
2.430400E-01 |
| Normal-vs-Extreme_Obese |
6.475500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.554600E-01 |
| Normal_Weight-vs-Obese |
7.504000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.996800E-01 |
| Extreme_Weight-vs-Obese |
7.404400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.134800E-01 |
| Obese-vs-Extreme_Obese |
3.487000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.605400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.483790E-01 |
| Normal-vs-Age(61-80Yrs) |
1.864150E-03 |
| Normal-vs-Age(81-100Yrs) |
1.233180E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.275250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.386300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.143600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.053040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.764300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.910300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.580100E-03 |
| Normal-VS-Type2 PRCC |
1.763000E-01 |
| Normal-VS-KIRP CIMP |
6.815000E-01 |
| Normal-VS-Unclassified PRCC |
6.619200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.254600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.071960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.362810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.433800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.471000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.236400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.492410E-02 |
| Normal-vs-N1 |
9.871200E-01 |
| Normal-vs-N2 |
9.403000E-01 |
| N0-vs-N1 |
1.078580E-01 |
| N0-vs-N2 |
4.117000E-01 |
| N1-vs-N2 |
9.770800E-01 |
|
|
